Press Releases
SCOR Global Life's embedded value results of 2013.
1128
document
May 6, 2014 — 00:00
SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%
document
April 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets.
document
April 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
document
April 30, 2014 — 00:00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
document
April 28, 2014 — 00:00
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
document
April 28, 2014 — 00:00
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
document
April 10, 2014 — 00:00
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
document
April 9, 2014 — 00:00
In December 2013 the Critical Illness Defi nitions and Geographical Variations Working Party presented their paper, ‘Extending the Critical Path’ to the Staple Inn Actuarial Society.
document
April 1, 2014 — 00:00
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
